We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Healthcare, R&D IT Conference

By Biotechdaily staff writers
Posted on 28 Feb 2006
The accessibility and availability of managed healthcare information and data originating from claims clearinghouses, electronic transaction companies, and electronic medical records (EMR)/electronic healthcare records (EHR) vendors are creating new opportunities to optimize the drug development process. More...
The emerging role of these data sources in clinical research processes will be the focus of the upcoming Drug Information Association's (DIA; Horsham, PA, USA) Research and Development (R&D) Meets Healthcare Information Technology (HIT) conference, March 26-29, 2006, in Philadelphia (PA, USA).

R&D Meets Healthcare IT will provide clinical researchers with the latest information on using emerging databases for site and patient recruitment, obtaining reliable data from claims clearinghouses and EMR/HER vendors, and other pertinent topics from leaders in the private and public sectors as well as from the U.S Food and Drug Administration (FDA). In his keynote address, Dr. Scott Gottlieb, the FDA deputy commissioner for medical and scientific affairs, will discuss the potential of EMR/HER to transform healthcare ad public health initiatives.

This conference is co-sponsored by the Healthcare Information and Management Systems Society (HIMSS; Chicago, IL, USA), and will be held concurrently with DIA's 21st Annual Clinical Data Management Symposium and Exhibition, allowing participants to attend numerous lectures and discussions and examine an expanded exhibit space.

The Drug Information Association serves professionals in the biotechnology, pharmaceutical, and regulatory industries worldwide. Through its U.S. and international meetings, training courses, workshops, and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes.



Related Links:
Drug Information Association

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.